Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2016

View Archived Issues

Special report: VHIO's Towards Predictive Cancer Models Symposium

Allergan discloses S1P1 ligands

New research alliance to discover novel treatments for severe fibrotic diseases

Biogen reports topline results from SYNERGY study

ALPK3 gene mutations identified in severe pediatric cardiomyopathy

Janssen begins first-in-human study of JNJ-63709178 for relapsed or refractory AML

Orphazyme cleared to begin AIDNPC intervention study of arimoclomol in U.S.

Tanaka Kikinzoku Kogyo develops kit to detect Zika virus in blood

Phase II dose selected for checkpoint inhibitor PDR-001 in first-in-human study

GlaxoSmithKline launches Nucala for bronchial asthma in Japan

Regulus Therapeutics announces phase II results on RG-101

Catabasis reports phase IIa topline data on CAT-2054 in hypercholesterolemia

FDA committee recommends approval of Teva's Vantrela ER

ABBV-399 shows promising antitumor activity for c-Met+ NSCLC

Skyepharma signs feasibility, development and license agreement with Lucideon

Pfizer announces phase II results of tofacitinib citrate

The role of RACK1 protein in development and progression of nasopharyngeal carcinoma

TapImmune exercises option agreement to Mayo Clinic HER2/neu vaccine technology

Novel xenograft models of digestive diseases

Sage Therapeutics reports promising phase I topline results for SAGE-217

Psilocybin shows promise in a feasibility trial as therapy for treatment-resistant depression

Sorrento and 3SBio form joint venture in China

Chiesi completes two pivotal studies of CHF-5993 for COPD

Axumin now available in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...